Clearday, Inc. (CLRD)
USD 0.07
(23233.33%)
USD 0.07
(23233.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 65.13 Million USD | -2.03% |
| 2021 | 66.47 Million USD | 2.88% |
| 2020 | 64.61 Million USD | 6500.47% |
| 2019 | 979 Thousand USD | 12.66% |
| 2018 | 869 Thousand USD | -1.7% |
| 2017 | 884 Thousand USD | -20.79% |
| 2016 | 1.11 Million USD | -10.22% |
| 2015 | 1.24 Million USD | -99.98% |
| 2014 | 6.79 Billion USD | -9.78% |
| 2013 | 7.53 Billion USD | 333.74% |
| 2012 | 1.73 Billion USD | -2.09% |
| 2011 | 1.77 Billion USD | 6.04% |
| 2010 | 1.67 Billion USD | -11.25% |
| 2009 | 1.88 Billion USD | 4.37% |
| 2008 | 1.8 Billion USD | -75.71% |
| 2007 | 7.43 Billion USD | 88.08% |
| 2006 | 3.95 Billion USD | -17.44% |
| 2005 | 4.78 Billion USD | -63.48% |
| 2004 | 13.1 Billion USD | -17.57% |
| 2003 | 15.9 Billion USD | 0.64% |
| 2002 | 15.8 Billion USD | 143.18% |
| 2001 | 6.49 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 41.31 Million USD | 11.74% |
| 2023 Q1 | 36.97 Million USD | -43.23% |
| 2023 Q3 | 44.17 Million USD | 6.92% |
| 2022 Q4 | 65.13 Million USD | 10.98% |
| 2022 Q2 | 70.77 Million USD | 1.75% |
| 2022 Q3 | 58.68 Million USD | -17.08% |
| 2022 Q1 | 69.55 Million USD | 4.63% |
| 2022 FY | 65.13 Million USD | -2.03% |
| 2021 Q1 | 722 Thousand USD | -98.88% |
| 2021 FY | 66.47 Million USD | 2.88% |
| 2021 Q2 | 668 Thousand USD | -7.48% |
| 2021 Q3 | 68.92 Million USD | 10217.98% |
| 2021 Q4 | 66.47 Million USD | -3.55% |
| 2020 Q4 | 64.61 Million USD | -81.32% |
| 2020 Q1 | 700 Million USD | -28.5% |
| 2020 Q2 | 588 Million USD | -16.0% |
| 2020 Q3 | 346 Million USD | -41.16% |
| 2020 FY | 64.61 Million USD | 6500.47% |
| 2019 Q1 | 1.38 Billion USD | 59.61% |
| 2019 Q3 | 1.14 Billion USD | -14.21% |
| 2019 Q2 | 1.33 Billion USD | -3.6% |
| 2019 FY | 979 Thousand USD | 12.66% |
| 2019 Q4 | 979 Million USD | -14.65% |
| 2018 Q4 | 869 Million USD | -14.55% |
| 2018 Q3 | 1.01 Billion USD | 15.7% |
| 2018 Q2 | 879 Million USD | -4.66% |
| 2018 Q1 | 922 Million USD | 4.3% |
| 2018 FY | 869 Thousand USD | -1.7% |
| 2017 Q1 | 936 Million USD | -16.13% |
| 2017 Q4 | 884 Million USD | 0.0% |
| 2017 FY | 884 Thousand USD | -20.79% |
| 2017 Q2 | 896 Million USD | -4.27% |
| 2016 Q4 | 1.11 Billion USD | -17.52% |
| 2016 FY | 1.11 Million USD | -10.22% |
| 2016 Q3 | 1.35 Billion USD | 6.79% |
| 2016 Q2 | 1.26 Billion USD | 14.04% |
| 2016 Q1 | 1.11 Billion USD | -10.62% |
| 2015 FY | 1.24 Million USD | -99.98% |
| 2015 Q4 | 1.24 Billion USD | -45.7% |
| 2015 Q3 | 2.28 Billion USD | -14.46% |
| 2015 Q2 | 2.67 Billion USD | -29.56% |
| 2015 Q1 | 3.79 Billion USD | -44.11% |
| 2014 Q1 | 8.19 Billion USD | 8.72% |
| 2014 FY | 6.79 Billion USD | -9.78% |
| 2014 Q4 | 6.79 Billion USD | -6.29% |
| 2014 Q3 | 7.25 Billion USD | -12.31% |
| 2014 Q2 | 8.27 Billion USD | 0.98% |
| 2013 Q2 | 1.77 Billion USD | -6.68% |
| 2013 Q3 | 6.55 Billion USD | 269.41% |
| 2013 FY | 7.53 Billion USD | 333.74% |
| 2013 Q4 | 7.53 Billion USD | 14.9% |
| 2013 Q1 | 1.9 Billion USD | 9.5% |
| 2012 Q4 | 1.73 Billion USD | -9.06% |
| 2012 FY | 1.73 Billion USD | -2.09% |
| 2012 Q1 | 2.9 Billion USD | 63.75% |
| 2012 Q2 | 2.37 Billion USD | -18.28% |
| 2012 Q3 | 1.91 Billion USD | -19.55% |
| 2011 Q1 | 2.61 Billion USD | 56.07% |
| 2011 Q4 | 1.77 Billion USD | -37.11% |
| 2011 Q2 | 1.86 Billion USD | -28.61% |
| 2011 Q3 | 2.82 Billion USD | 51.34% |
| 2011 FY | 1.77 Billion USD | 6.04% |
| 2010 FY | 1.67 Billion USD | -11.25% |
| 2010 Q1 | 2.49 Billion USD | 32.2% |
| 2010 Q2 | 2.58 Billion USD | 3.73% |
| 2010 Q4 | 1.67 Billion USD | -35.31% |
| 2010 Q3 | 2.58 Billion USD | 0.04% |
| 2009 Q3 | 3.03 Billion USD | -7.87% |
| 2009 Q1 | 2.03 Billion USD | 0.0% |
| 2009 Q2 | 3.29 Billion USD | 61.43% |
| 2009 FY | 1.88 Billion USD | 4.37% |
| 2009 Q4 | 1.88 Billion USD | -37.81% |
| 2008 Q3 | 2.4 Billion USD | -19.36% |
| 2008 Q2 | 2.98 Billion USD | -17.61% |
| 2008 Q1 | 3.61 Billion USD | -51.35% |
| 2008 Q4 | - USD | -100.0% |
| 2008 FY | 1.8 Billion USD | -75.71% |
| 2007 FY | 7.43 Billion USD | 88.08% |
| 2007 Q1 | 3.36 Billion USD | -14.85% |
| 2007 Q4 | 7.43 Billion USD | 72.19% |
| 2007 Q3 | 4.31 Billion USD | 21.16% |
| 2007 Q2 | 3.56 Billion USD | 5.88% |
| 2006 FY | 3.95 Billion USD | -17.44% |
| 2006 Q4 | 3.95 Billion USD | 0.0% |
| 2006 Q2 | 4.19 Billion USD | -5.73% |
| 2006 Q1 | 4.44 Billion USD | -7.12% |
| 2005 Q4 | 4.78 Billion USD | -13.79% |
| 2005 FY | 4.78 Billion USD | -63.48% |
| 2005 Q1 | 11.83 Billion USD | -9.7% |
| 2005 Q2 | 5.55 Billion USD | -53.12% |
| 2005 Q3 | 5.55 Billion USD | 0.07% |
| 2004 Q3 | 8.74 Billion USD | -10.74% |
| 2004 Q2 | 9.8 Billion USD | -22.74% |
| 2004 Q1 | 12.68 Billion USD | -20.23% |
| 2004 Q4 | 13.1 Billion USD | 49.85% |
| 2004 FY | 13.1 Billion USD | -17.57% |
| 2003 FY | 15.9 Billion USD | 0.64% |
| 2003 Q2 | 18.67 Billion USD | 7.44% |
| 2003 Q4 | 15.9 Billion USD | -6.78% |
| 2003 Q3 | 17.06 Billion USD | -8.66% |
| 2003 Q1 | 17.38 Billion USD | 10.02% |
| 2002 Q1 | 7.38 Billion USD | 13.6% |
| 2002 Q2 | 8.2 Billion USD | 11.14% |
| 2002 Q3 | 7.77 Billion USD | -5.28% |
| 2002 Q4 | 15.8 Billion USD | 103.35% |
| 2002 FY | 15.8 Billion USD | 143.18% |
| 2001 Q3 | 7.39 Billion USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | 6.49 Billion USD | 0.0% |
| 2001 Q4 | 6.49 Billion USD | -12.11% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -163.59% |
| Arem Pacific Corporation | 304.9 Thousand USD | -21261.578% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -35265.778% |
| BioCorRx Inc. | 10.34 Million USD | -529.818% |
| Bionik Laboratories Corp. | 5 Million USD | -1201.935% |
| Banyan Corp. | 4.51 Million USD | -1341.475% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -3514.231% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -4330433.637% |
| Empower Clinics Inc. | 9.18 Million USD | -609.057% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -105.767% |
| Selectis Health, Inc. | 43.63 Million USD | -49.265% |
| Ethema Health Corporation | 17.71 Million USD | -267.574% |
| HealthLynked Corp. | 3.47 Million USD | -1774.084% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -349.97% |
| JRSIS Health Care Corporation | 2.3 Million USD | -2725.47% |
| Comjoyful International Company | 6.32 Million USD | -929.578% |
| Medical Facilities Corporation | 235.37 Million USD | 72.328% |
| MedSmart Group Inc. | 927.53 Thousand USD | -6922.093% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -6852.243% |
| Nova Leap Health Corp. | 2.69 Million USD | -2313.233% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -2159.857% |
| PAO Group, Inc. | 1.04 Million USD | -6123.434% |
| Primemd Inc. | 7.98 Million USD | -715.303% |
| Raffles Medical Group Ltd | 367.04 Million USD | 82.255% |
| Ryman Healthcare Limited | 5.17 Billion USD | 98.743% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -80784.312% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -1563.307% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -1433.341% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -9534.925% |
| Veltex Corporation | 2.87 Million USD | -2163.702% |
| World Financial Holding Group | 132.5 Thousand USD | -49054.441% |
| Xcelerate Inc. | 2.07 Million USD | -3038.034% |